No Prescription » Prescription Drugs 5 » Dalacin C Cleocin
Clindamycin is used to treat a wide variety of bacterial infections. It is an antibiotic that works by stopping the growth of bacteria.This antibiotic treats only bacterial infections. It will not work for virus infections (e.g. common cold flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used before dental procedures in patients with certain heart conditions (e.g. artificial heart valves) to help prevent serious infection of the heart (bacterial endocarditis).How to use Clindamycin HCl OralTake this medication by mouth with or without food usually 4 times a day (every 6 hours) or as directed by your doctor. Take it with a full glass of water (8 ounces or 240 milliliters) unless your doctor directs you otherwise. Do not lie down for at least 30 minutes after taking this medication.The dosage is based on your medical condition and response to treatment. In children the dose is also based on weight.Antibiotics work best when the amount of medicine in your body is kept at a constant level. Therefore take this drug at evenly spaced intervals.Continue to take this medication until the full prescribed amount is finished even if symptoms disappear after a few days. Stopping the medication too early may result in a return of the infection.
Buy Dalacin C Cleocin and other Prescription Drugs 5 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Dalacin C Cleocin:
Product Type: Prescription Drugs 5
Dalacin C ( Cleocin Generic Clindamycin )
Dalacin C (Cleocin Generic Clindamycin)
Cleocin Generic Clindamycin
150mg 16 Tablets 48(3 x 16) Tablets
Cleocin Generic Clindamycin Dalacin C

View more
Prescription Drugs 5
Previous Product Next Product
No Prescription:
NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.


|